REHOVOT, Israel, June 14 /PRNewswire/ -- Rosetta Genomics and Rockefeller University today announced the signing of a licensing agreement that will allow Rosetta Genomics to access nearly 180 proprietary microRNAs from Rockefeller University. These microRNAs will be added to Rosetta Genomics’s microRNA database, providing the company with additional biomarker candidates for its diagnostic development programs. Under the terms of the agreement, Rosetta Genomics will be able to use these microRNAs to potentially advance multiple research development programs targeting new microRNA based diagnostic tools for a variety of diseases.
